Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Saag, MD
UAB Center for AIDS Research
Principal Investigator - Susan W Cox, Ph D
Avexa Ltd
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
100 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- 407 Doctors
Darlinghurst, New South Wales, Australia
- Parramatta Sexual Health Clinic
Parramatta, New South Wales, Australia
- Westmead Hospital
Westmead, New South Wales, Australia
- Carlton Clinic
Carlton, Victoria, Australia
- Melbourne Sexual Health Centre
Carlton, Victoria, Australia
- the Alfred
Melbourne, Victoria, Australia
- Royal Melbourne Hospital
Parkville, Victoria, Australia
- Prahran Market Clinic
South Yarra, Victoria, Australia
- Prins Leopold Institute Voor Tropische Geneeskunde
Antwerp, Belgium
- Cliniques Universitaires Saint-Luc
Brussels, Belgium
- Hopitaux Iris Sud
Brussels, Belgium
- Ubc Downtown I.D. Clinic
Vancouver, British Columbia, Canada
- Hamilton Health Sciences Corporation
Hamilton, Ontario, Canada
- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- University Health Network
Toronto, Ontario, Canada
- Centre Hospitalier Universitaire de Quebec
Québec, Quebec, Canada
- Charite-Universitatsmedizin Berlin
Berlin, Germany
- Epimed Gmbh
Berlin, Germany
- Ruhr-Universitat Bochum
Bochum, Germany
- Universitatsklinikum Bonn
Bonn, Germany
- Klinikum Dortmund Ggmbh
Dortmund, Germany
- Universitatsklinikum Essen
Essen, Germany
- Klinikum Der Johann-Wolfgang Goethe-Universitat
Frankfurt, Germany
- Praxis Fuer Innere Medizin
Freiburg im Breisgau, Germany
- Praxis Dr.Schneider
Fürth, Germany
- Dr. Med. Birger Kuhlmann
Hanover, Germany
- Klinikum Der Universitat Munchen - Innenstadt
München, Germany
- Gemeinschaftspraxis E. Schnaitmann, Dr. Med. A. Schaffert, Dr. Med. A. Trein, Dr. Med. E. Ibler
Stuttgart, Germany
- Praxis Dres. Ulmer, Frietsch, Muller
Stuttgart, Germany
- Soroka University Medical Center
Beersheba, Israel
- Rambam Medical Center
Haifa, Israel
- Hadassah University Hospital Ein Kerem
Jerusalem, Israel
- the Chaim Sheba Medical Center
Ramat Gan, Israel
- Kaplan Medical Center
Rehovot, Israel
- Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel
- Ospedale S.Maria Annunziata
Antella, Italy
- Azienda Ospedaliera Universitaria Di Ferrara Arcispedale S.Anna
Ferrara, Italy
- Azienda Ospedaliera Universitaria San Martino
Genova, Italy
- Fondazione Centro San Raffaele del Monte Tabor
Milan, Italy
- Ospedale Luigi Sacco
Milan, Italy
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2008
- Primary completion
- 31 Jan 2010
- Completion
- 31 Jan 2010
- Last update posted
- 23 Jan 2012
- Registered enrollment
- 239
- Registry id
- NCT00612898
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.